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Cellular processes are crucially dependent on dynamic receptor-ligand interactions occurring at the interface between the cell membrane and the extracellular matrix (ECM).
[1] Changes in these interactions as ac onsequence of ECM remodeling give rise to specific cell-signaling and intracellular cascades.T hese processes are central to physiology and pathological processes,s uch as tissue self-repair and tumorigenesis. [1b,c] As mimics of such dynamic interactions,a rtificial matrices with the reversible display of bioactive ligands have attracted much attention. Surfaces capable of modulating cell-biomaterial interactions are commonly exploited for in situ cell-biology experimentation and in tissue engineering. [1c,2] Furthermore,adynamic biointerface with reversibly immobilized ligands has also shown great promise in drug targeting and isolation methods for therapeutics and diagnostics. [3] Current methods to control reversible ligand presentation on biomaterial interfaces mainly rely on surface functionalization with reversible linkers (e.g.,noncovalent or reversible covalent interactions) to which the bioactive ligand is tethered. Forexample,bymeans of host-guest interactions, [4] reversible covalent interactions, [5] molecular assembly, [6] or other multiple noncovalent interactions, [7] the integrin-targeted cell-adhesive peptide RGD (Arg-Gly-Asp) [8] could be dynamically and reversibly immobilized on biointerfaces to regulate cell-adhesion behavior. These approaches towards the simulation of reversible ligand presentation in abiological system have greatly promoted the development of dynamic biointerfaces and anew generation of artificial ECM materials.T od ate,o nly af ew reversible linkage chemistries have been exploited. In view of the vast number of natural receptor-ligand pairs in biology,f urther effort is warrented. Linkages mimicking the exquisite complementarity exhibited by natural ligand-receptor pairs are particularly attractive, [9] but current strategies in this direction still leave significant room for improvement.
To attain molecularly tunable reversibility in analogy with natural receptor-ligand interactions we turned to molecular imprinting and molecularly imprinted polymers (MIPs). [10] Ther ecognition sites in MIPs,g enerally created by at emplate-imprinting process,a re spatially complementary to the shape and functionality of the template molecules.
[10a-c] Thus, molecular recognition in MIPs occurs by a" lock and key" mechanism similar to natural receptor-ligand interactions.In contrast to the scarce number of dynamic covalent or hostguest-based linkages, [11] imprinting can be used to tailor reversible affinity towards various ligands,i ncluding small molecules,p eptides,a nd proteins. [12] It has been shown that MIPs now can challenge and even exceed the performance of antibodies in affinity related applications both in vitro and in vivo. [12a, 13] To date,however,few attempts have been made to use molecular imprinting for the reversible introducation of surface bioactivity. [14] Recently,w ed esigned an RGD-peptide-imprinteds ubstrate to assist fast cell-sheet harvesting.
[12c] Given that we then used bioactive ligands as templates per se in that system, template binding would produce two counteracting effects: 1) it would concentrate the bioactive molecules near the interface,a nd 2) tightly bound bioactive molecules would be unaccessible for receptor binding.
To address the latter problem, we employed in this study an epitope-imprinting strategy [15] for introducing cell-adhesive RGD in af ully exposed form. Thep rinciple is based on the use of ashort peptide (the epitope) as template during the imprinting process and subsequently use of this epitope as an RGD tag for anchoring the RGD sequence to the substrate surface.I nt his design, the epitope peptide could act as ar eversible anchor of RGD peptide,t hus leaving the latter exposed for interaction with cell-surface integrin receptors. Moreover,t he addition of an appropriate amount of epitope peptide to the system would induce gradual release of the bound RGD-based peptides through competitive molecular exchange;that is,the bioactivity at the material interface can be dynamically controlled.
To obtain high epitope affinity in the resultant MIPs for stable RGD anchoring,w ef ocused on charged peptide sequences capable of engaging in multiple ionic interactions with af unctional monomer.E xploitation of the amidinecarboxylate interaction seemed particularly worthwhile given its high stability in competitive solvents and previous success in molecular imprinting, [16] for example,t he use of benzamidine-bearing monomers for stoichiometric imprinting. [13a, 16b,c] Thee pitope-imprinted biointerface (EIB) was prepared by am icrocontact imprinting method (Scheme 1). [17] As ap roof-of-concept, as tructurally symmetrical and carboxylrich peptide (DDDGGDDD) was used as the epitope peptide template for imprinting.Meanwhile,abioactive long peptide (DDDGGDDDSSSSSRGDS) consisting of the epitope tag (DDDGGDDD) at the N-terminus,ahydrophilic spacer (SSSSS) in the middle,a nd an integrin-targeted peptide (RGDS) at the C-terminal end, was designed for subsequent peptide rebinding and cell-recognition experiments.B efore microcontact imprinting,the epitope template was covalently immobilized on ac over glass at the C-terminal end (see Figure S1 in the Supporting Information). Theimprinting was subsequently performed between the cover glass with the immobilized epitope and am ethacrylate-modified quartz substrate (10 mm in diameter). Thep olymerization reaction was photochemically initiated by aU Vl amp after dripping 3 mLo faphosphate buffer solution (PBS,0 .02 m,p H7.4) containing 1m 2-hydroxyethyl acrylamide (hydrophilic backbone monomer), 0.01m 4-acrylamidophenyl(amino)-methaniminium chloride (benzamidine-bearing monomer; see Figure S2 ), [13d] and 0.05 m methylenebisacrylamide (cross-linker) onto the cover glass.B yp olymerization and peeling of the cover glass,apeptide-imprinted layer (ca. 4 mm; see Figure S3 ) on the quartz substrate with oriented recognition sites for DDDGGDDD was readily obtained (see the Supporting Information). This epitope-imprinted biointerface (EIB) was subsequently employed to reversibly anchor the Scheme 1. Generation of an epitope-imprinted biointerface (EIB) and dynamic cell adhesion.
epitope-tagged bioactive peptide DDDGGDDDSSSSS-RGDS.
Thee pitope-peptide affinity of EIB and its control NIB (non-imprinted biointerface) was first studied by isothermal adsorption experiments.B yu sing C-terminally fluorescein isothiocyanate (FITC) labeled peptides (see Figures S4-S11 ) the amount of bound peptide could be indirectly determinated by recording the changes in fluorescence intensity in solution. Thus,f or isothermal adsorption, EIB or NIB was incubated in PBS solutions of FITC-labeled epitope (DDDGGDDDSSSSSK-FITC) at different concentrations. Theh ydrophilic spacer SSSSS we anticipated would reduce the nonspecific binding of the labeled peptide to the EIB and NIB.After incubation for 12 htoensure equilibrium adsorption, the amount of bound epitope peptide on EIB and NIB was quantified. EIB showed significantly higher peptidebinding capacity as compared to NIB over aw ide range of peptide concentrations (Figure 1a ). Scatchard analysis also revealed ah igher association constant of EIB (K a = 9.75 10 7 m À1 )t han that of NIB (K a = 0.81 10 7 m À1 ), thus preliminarily indicating the successful imprinting of the epitope peptide on EIB (see Figure S12 and Table S1 ). Meanwhile, the apparent maximum number of recognition sites (i.e., imprinting sites) on EIB was estimated to be 7.35 pmol cm
À2
. Although the theoretical amount of imprinting sites on EIB was only one third of those of apreviously reported epitopeimprinted film, the K a value in this study was seven times higher. [15] Such strong binding affinity could be ascribed to the multiple electrostatic interactions between carboxy and benzamidine groups in the imprinting sites during peptide rebinding. Thes electivity of EIB and NIB towards the epitope peptide was also examined to further confirm the imprinting mechanism (Figure 1b) . Theb inding capacity of EIB and NIB towards the FITC-labeled epitope (DDDGGDDDSSSSSK-FITC), aF ITC-labeled scrambled peptide with as imilar symmetrical structure (GGGDDGGGSSSSSK-FITC), and aF ITC-labeled spacer peptide (SSSSSK-FITC) was compared. In line with the results of isothermal adsorption, EIB showed significantly higher binding capacity towards the epitope peptide than NIB.H owever,t he binding capacity of EIB towards the scrambled peptide and the spacer peptide was significantly lower as compared to the epitope peptide.Asexpected, there was no significant difference in the binding capacity of NIB towards the three different peptides.T he high selectivity featured by EIB towards the epitope peptide confirms the presence of specific recognition sites for the epitope as imparted by the imprinting process.
To investigate the dynamic binding properties,w e immersed FITC-peptide-loaded EIB and NIB in PBS and subsequently followed peptide release by monitoring the substrate fluorescence intensity (Figure 2a) . After incubation for 12 h, the fluorescence intensity of EIB had decreased by only 27 %, whereas the fluorescence on NIB had decreased by nearly 50 %. More importantly,t he fluorescence on EIB at 12 hwas still more than three times stronger than that on NIB, thus demonstrating the stability of the bound epitope on EIB. In contrast, when it was incubated in PBS with free epitope peptide (0.1 mg mL À1 ), the fluorescence intensity on EIB decreased dramatically (only 25 %l eft after overnight incubation). Also,w ef ound that EIB and NIB both exhibited weak fluorescence intensity after incubation with free epitope peptide for 12 h ( Figure 2b ). This phenomenon is similar to observations in previously reported studies,i nw hich reversible covalent or host-guest interactions could be switched by ac ompetitive molecular exchange. [4b,5] According to the binding isotherms,t he surface-bound amount of epitope peptide on EIB (initial epitope concentration:5 1.8 nm)w as estimated to be 8.9 ng,w hich is far less than the amount of free epitope in solution (0.1 mg mL À1 in 1mLo fP BS). Thus, the surface-bound peptide could be readily exchanged by the free epitope peptide,t hus leading to ad ramatic decrease in surface fluorescence intensity.T hese results demonstrated that EIB could not only bind the epitope peptide with high affinity but also release it through an epitope-moleculeexchange process. EIB and NIB were then incubated in as olution with the epitope-tagged RGD peptide DDDGGDDDSSSSSRGDS (51.8 nm in PBS) to introduce integrin-targeted peptide RGD on the surface.T he surface bioactivity of RGD was checked with integrin a v b 3 ,acell-membrane receptor. [8a] Atomic force microscopy (AFM) demonstrated that integrin a v b 3 could be efficiently recognized and bound to the RGD-modified surface (see Figure S13) , thus confirming the existence and accessibility of the surface-bound RGD for cell recognition. We then checked the cell-adhesion behavior of the RGDbound EIB and NIB by seeding mouse 3T3 fibroblasts on them (Figure 3 ). Without binding with RGD,t he cell morphology only showed at ypical non-adhesive round shape (Figure 3a ,c) after culture for 3h in a-minimal essential medium (a-MEM) supplemented with 10 %f etal bovine serum (FBS). After rinsing, almost no cells could adhere to either EIB or NIB.This cell-repellant property is presumably due to the high hydrophilicity of EIB and NIB (see Figure S14) and thus reduced nonspecific protein adsorption. In contrast, the cell-adhesion behavior on EIB was dramatically increased following RGD introduction. We observed as ignificant increase in adhered cells with at ypical spreading shape on the RGD-modified EIB (Figure 3d ;s ee also Figure S15 ). Also,E IB modified with different amounts of RGD all exhibited enhanced cell adhesion (see Figure S16) . However,c ells on the RGD-modified NIB still featured the non-adhered round shape.S uch as ignificant difference between EIB and NIB can be ascribed to the markedly lower epitope-binding constant of NIB,w hich resulted in weak affinity and low uptake of the peptide by this substrate. Poor cell adhesion was also observed on EIB modified with epitope-tagged non-adhesive RGE peptide DDDGGDDDSSSSSRGES,t hus further confirming the RGD/integrin-triggered cell-adhesion mechanism (Figure 3e) .
We further applied 4'-6-diamidino-2-phenylindole (DAPI) and fluorescein phalloidin to stain the nuclei and Factin of the adhered cells.T he F-actin networks of cells on RGD-modified EIB exhibited typical focal adhesion patterns and spreading shape (inset in Figure 3d ;see also Figure S17 ). However,only sporadic round cells with no stress fibers were found for the other groups after cell staining. Taken together, these results demonstrated that the peptide-recognition sites created by epitope imprinting could be employed to introduce an integrin-targeted RGD peptide on am aterial surface and thereby induce specific cell adhesion.
Thea bove peptide-release experiments verified that the bound epitope on EIB could be released by an epitopetriggered molecule-exchange process.T hus,c ell detachment from EIB was further examined to determine whether the cell-adhesion behavior could be reversed by adding free epitope peptide to the medium. First, EIB was modified with DDDGGDDDSSSSSRGDS. After incubation for 3h to allow cell spreading,t he initial cell-culture medium a-MEM was changed to another a-MEM medium containing 0.1 mg mL À1 free epitope DDDGGDDD.Agradual transition of the cell morphology from as pread-out shape to ar ound shape was clearly observed in the first 4.5 h (Figure 4) . After incubation for 12 h, more than 90 %o ft he adhered cells on EIB had been released (Figure 4 ). In contrast, no significant cell-morphology change was observed on EIB without addition of the free epitope (see Figure S18 ). This result demonstrated the molecule-exchange-induced cell-release property of our system. Thec ell-release rate was much slower than for our previously reported biointerface based on monosaccharide-responsive dynamic covalent bonds. [5] We believe that the slower rate is due to the high peptide affinity of EIB and mass-transfer limitations at the imprinted sites.T he released cells could re-adhere on an ew petri dish, thus implying that the molecule-exchange-induced cell release from EIB occurs in anon-invasive manner.
In summary,w eh ave developed an epitope-imprinted biointerface for the reversible presentation of bioactivity and dynamic control of cell-material interactions.T he surface molecular-recognition sites,prepared by the epitope-imprinting process,could be used to bind an epitope-tagged bioactive peptide featuring the epitope tag at one terminus and ac elladhesive peptide RGD at the other terminus.O wing to the ). Scale bar:5 0mm. The histogramont he right-hand side indicates that the numbero fadhered cells had significantly decreased after incubation for 12 h. Statistically significant differences are indicated by * p < 0.001 as compared with others.
reversible-binding property,t he epitope-imprinted biointerface exhibited dynamic RGD presentation and subsequently controllable cell-adhesive behavior.A sc ompared to the limited chemical means to achieve dynamic biointerfaces, such abiomimetic interaction may unlock new applications in cell biology,diagnostics,a nd regenerative medicine.
